Abstract:Whole brain radiotherapy (WBRT) remains reference treatment in patients with brain metastasis (BM), especially with multiple lesions. Hippocampus avoidance in WBRT (HA-WBRT) offers the feasibility of less impaired cognitive function than conventional WBRT and better intracranial control than SBRT. Oncological safety is critical in defining the proper role of HA-WBRT. The study aims to investigate the frequency of intracranial substructure involvement based on large series of radiological data and to optimize the margin definition in treatment planning. Consecutive patients with diagnosis of BM from enhanced MRI between 03/2011 and 07/2016 in RuiJin Hospital were analyzed. Lesions of each patient were confirmed by a senior radiologist and the closest distances from tumor to the hippocampal area were measured. A total of 226 patients (male 115/226, female 111/226) with 1080 metastatic sites are reviewed. The distribution of the primary tumors were: 72.6% from lung cancer (164/226), 19.9% from breast cancer (45/226) and 7.5% from other malignancies (17/226). Seventy-one patients had BM before or simultaneously with their primary malignancy, among them, 64 were with primary lung cancer. In the other 155 patients, the average and median time from the diagnosis of primary disease to the diagnosis of BM were 14 m and 9 m in patients with lung cancer (100/155), 59 m and 34 m in patients with breast cancer (42/100). In total, 758/1080(70.2%) lesions were situated beyond the tentorium. The average maximum diameters of single lesion were 13.82mm ±14.67mm and median diameters were 10mm(1.2mm-162mm).The distribution of the lesions were as follows: 322(29.8%) in the cerebellum, 268(24.8%)in the frontal lobe,168(15.6%)in the temporal lobe,128(11.9%) in the parietal lobe, 131(12.1%)in the occipital lobe, 45(4.2%)in the thalamus and 18(1.6%) in the brainstem. After measuring the closest distance from lesions to the Hippocampus area in each patients, the definition and the frequency of Hippocampus involvemt can be classifed into 3 catogories: 7/226(3.1%) within 5mm or less, 13/226(5.7%) within 10mm or less and 19/226(8.4%) within 20mm or less. 18 of 45 patients who had complete radiological follow-up after WBRT in the same hospital were founded progress of BM. The median time of follow-up is 11 months. There was only one new lesions in area of Hippocampus (less than 5mm). With complete radiological diagnosis, HA-WBRT can be delivered with oncological safety. Proper margin definition of HA in delineation is to be confirmed with individual technique.

High Incident of EGFR Mutant for Lung Cancer Brain Metastases Patients and Low Risk of Brain Metastases in Hippocampus

A Analysis of the Spatial Distribution Characteristics of Brain Metastasis and the Risk of Hippocampus Metastasis in Patients with EGFR Mutant Lung Cancer

[Prognostic Analysis of EGFR-TKIs Combined with Gamma Knife in EGFR-mutant Lung Adenocarcinoma with Brain Metastasis].

EP12.01-40 the Optimal Intervention Timing of Aumolertinib Combined with HFSRT for EGFR Mutated NSCLC Patients with Multiple Brain Metastasess

Quick Regression of Brain Metastases from Lung Adenocarcinoma with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor Treatment: A Case Report and Literature Review.

Whole Brain Radiotherapy-Based Combined Modality Treatment of Brain Metastases from Non-Small Cell Lung Cancer: A Retrospective Analysis of Prognostic Factors

Outcomes of 27 Non-Small Cell Lung Cancer Patients Receiving Resections of Paired Primary Pulmonary and Brain Metastatic Tumours: Is EGFR Negative Mutation of Brain Metastasis Bring More Benefit?

A Radiological Analysis Of Oncological Safety Of Whole Brain Radiation Therapy With Hippocampus Avoidance In Patients With Brain Metastasis

EGFR-Tyrosine Kinase Inhibitor Combined with Radiotherapy in 105 Patients of Lung Adenocarcinoma with Brain Metastasis: A Retrospective Study of Prognostic Factor Analysis

Radiological Features of Non-Small-cell Lung Cancer with Brain Metastases in a Single Center: an Implication for the HA-WBRT Approach

83P Cerebral Toxicity of Whole Brain Radiotherapy Plus Icotinib in Rats

Gamma Knife Surgery for Brain Metastasis from Hepatocellular Carcinoma.

Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer

Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases

Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib

Epidermal growth factor receptor mutations: association with favorable local tumor control following Gamma Knife radiosurgery in patients with non–small cell lung cancer and brain metastases

Efficacy of EGFR-TKI Therapy in Patients with Brain Metastases from Non-Small-cell Lung Cancer: A Meta-Analysis

Radiological Distribution of Brain Metastases and Its Implication for the Hippocampus Avoidance in Whole Brain Radiotherapy Approach

Treatment Modes for EGFR Mutations in Patients with Brain Metastases from Non-Small Cell Lung Cancer: Controversy, Causes, and Solutions

A real-world study in advanced non-small cell lung cancer with de novo brain metastasis

Cmar_a_196881 3433..3443